Most Viewed Articles
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
1,131 | 85,420 | 86,551 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
2,321 | 82,724 | 85,045 |
CommentaryStatus of research and publication in IndiaFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
1,832 | 73,075 | 74,907 |
EditorialEczema and skin allergy-focus on researchFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
1,057 | 60,134 | 61,191 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
2,383 | 43,545 | 45,928 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
1,922 | 39,371 | 41,293 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
1,624 | 38,175 | 39,799 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
1,849 | 36,551 | 38,400 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
880 | 34,786 | 35,666 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
2,303 | 23,788 | 26,091 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
1,137 | 20,410 | 21,547 |
Case ReportA novel pitch against the itchFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
2,221 | 18,190 | 20,411 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
1,812 | 17,972 | 19,784 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
3,247 | 13,240 | 16,487 |
ImageGiant fixed drug eruptionFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
1,968 | 13,578 | 15,546 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
1,337 | 12,849 | 14,186 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
1,305 | 10,762 | 12,067 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
1,124 | 10,704 | 11,828 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
1,530 | 9,933 | 11,463 |
SymposiumCutaneous photobiologyFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
1,942 | 8,398 | 10,340 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
1,972 | 8,252 | 10,224 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDFYear: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
8,730 | 1,392 | 10,122 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
1,829 | 7,996 | 9,825 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_4_2024 |
1,511 | 8,196 | 9,707 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_31_2024 |
945 | 8,266 | 9,211 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
2,150 | 7,041 | 9,191 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
2,092 | 6,747 | 8,839 |
SymposiumPolymorphous light eruptionsFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
1,155 | 7,674 | 8,829 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
2,028 | 6,739 | 8,767 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
1,301 | 7,247 | 8,548 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
1,392 | 6,938 | 8,330 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
1,373 | 6,807 | 8,180 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDFYear: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
7,028 | 1,041 | 8,069 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_41_2024 |
1,094 | 6,582 | 7,676 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_21_2024 |
1,079 | 6,549 | 7,628 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
2,322 | 5,293 | 7,615 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
2,200 | 5,294 | 7,494 |
SymposiumChronic actinic dermatitisFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
1,122 | 6,222 | 7,344 |
Review ArticleJAK inhibitors in dermatologyFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
4,604 | 1,239 | 5,843 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_20_2024 |
1,257 | 4,354 | 5,611 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
2,807 | 1,794 | 4,601 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDFYear: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
2,987 | 876 | 3,863 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDFYear: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
2,673 | 1,110 | 3,783 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_30_2024 |
792 | 2,869 | 3,661 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
2,677 | 858 | 3,535 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
1,755 | 1,764 | 3,519 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDFDOI: 10.25259/IJSA_41_2023 |
1,042 | 2,443 | 3,485 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
2,783 | 642 | 3,425 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_8_2023 |
1,734 | 1,661 | 3,395 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_3_2023 |
2,378 | 902 | 3,280 |